Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$393K Sell
11,774
-1,078
-8% -$39.5K ﹤0.01% 4507
2014
Q2
$479K Buy
12,852
+2,751
+27% +$82.6K ﹤0.01% 4261
2014
Q1
$300K Buy
10,101
+714
+8% +$20.5K ﹤0.01% 4762
2013
Q4
$259K Buy
9,387
+8,303
+766% +$194K ﹤0.01% 5008
2013
Q3
$24K Sell
1,084
-67,858
-98% -$1.19M ﹤0.01% 7805
2013
Q2
$1.07M Buy
+68,942
New +$1.13M ﹤0.01% 3253

Other funds holding AGX

UBS's AGX Position: Q3 2014 in Review

UBS reduced its Argan (AGX) stake by 8.4% in Q3 2014, selling an estimated $39.5K and leaving 11,774 shares worth $393K. The position accounts for ﹤0.01% of the portfolio, ranked #4507.

UBS first reported a position in AGX in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.07M in Q2 2013. 131 funds tracked by Wall St. Rank hold AGX as of Q3 2014.

  • UBS held 11,774 shares of Argan worth $393K as of Q3 2014.
  • UBS sold 1,078 Argan shares in Q3 2014, an estimated $39.5K.
  • Argan made up ﹤0.01% of UBS's portfolio in Q3 2014, its #4507 holding.
  • UBS first reported a position in Argan in Q2 2013 and has held it in 6 quarters since.
  • UBS's Argan position peaked at $1.07M in Q2 2013.
  • 131 funds tracked by Wall St. Rank held Argan as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.